Skip to content

Peripheral blood and uterine hemomics study of adenomyosis

Peripheral blood and uterine hemomics study of adenomyosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118333
Enrollment
Unknown
Registered
2026-02-04
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Uterine fibroids group:None

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients with adenomyosis: aged 30 to 50, with dysmenorrhea and/or menorrhagia, color Doppler ultrasound and/or magnetic resonance imaging indicating adenomyosis, and hemoglobin greater than 60g/L; 2. Patients with uterine fibroids: aged 30 to 50, with color Doppler ultrasound and/or magnetic resonance imaging indicating uterine fibroids, and hemoglobin greater than 60g/L.

Exclusion criteria

Exclusion criteria: 1. Complicated with endometriosis such as endometriosis cysts;2. Combined with other systemic diseases such as diabetes, hypertension, hyperlipidemia, autoimmune diseases, etc.;3. Complicated with other diseases affecting coagulation function;4. Transfusion patients;5. Recent use of sex hormone therapy.

Design outcomes

Primary

MeasureTime frame
Analysis of plasma omics;

Secondary

MeasureTime frame
Coagulation function;Platelet;

Countries

China

Contacts

Public ContactWu Qing

Zhejiang Provincial People's Hospital

okwq31@163.com+86 151 6717 0568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026